Related Experiment Videos
Web alert. Molecular vaccines for disease prevention and therapy
1Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1T 4LB, UK. daniel.jones@current-drugs.com
Current Opinion in Molecular Therapeutics
|March 16, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.
American journal of clinical oncology·1995
Sports and recreation injuries in US children and adolescents.
Archives of pediatrics & adolescent medicine·1995
Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression.
Molecular and cellular biology·1995
Characterization of a 17-kilodalton antigen of Bartonella henselae reactive with sera from patients with cat scratch disease.
Journal of clinical microbiology·1995
Gene therapy: Have the risks associated with viral vectors been solved?
Current opinion in molecular therapeutics·2011
Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
Current opinion in molecular therapeutics·2010
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.
Current opinion in molecular therapeutics·2010
Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.
Current opinion in molecular therapeutics·2010
Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.
Current opinion in molecular therapeutics·2010
Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.
Current opinion in molecular therapeutics·2010
Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.
Biomaterials science·2026
Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
Current pharmaceutical design·2026
Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.
Current neurovascular research·2026
Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.
Anatolian journal of cardiology·2026
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.
Journal of clinical pharmacology·2026